Skip to main
AIP

Arteris (AIP) Stock Forecast & Price Target

Arteris (AIP) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Arteris Inc. reported a remarkable 72% quarter-over-quarter increase in royalty revenue, fueled by the successful transition of more licensee products into production. The company has provided an optimistic revenue guidance of approximately $69.0 million for the full year, reflecting a 19.7% year-over-year increase, with positive free cash flow achieved at the higher end of expectations. Additionally, the imminent acquisition of Cycuity is anticipated to enhance Arteris’s customer base, amplify value for existing clients, and accelerate revenue growth, showcasing confidence in future scalability.

Bears say

Arteris Inc. faces potential revenue pressures due to macroeconomic uncertainties that could negatively impact the broader semiconductor industry. The company's reliance on license revenue and the unpredictability of capturing design wins raises the risk of incurring substantial expenses without corresponding revenue generation. Furthermore, a possible shift away from Arteris's solutions could result in diminished average selling prices, loss of market share, and adverse effects on overall revenue performance.

Arteris (AIP) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Arteris and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Arteris (AIP) Forecast

Analysts have given Arteris (AIP) a Strong Buy based on their latest research and market trends.

According to 2 analysts, Arteris (AIP) has a Strong Buy consensus rating as of Apr 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Arteris (AIP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.